106 related articles for article (PubMed ID: 4422945)
1. Prolonged alteration of renin responsiveness after spironolactone therapy. A cause of false-negative testing for low-renin hypertension.
Lowder SC; Liddle GW
N Engl J Med; 1974 Dec; 291(23):1243-4. PubMed ID: 4422945
[No Abstract] [Full Text] [Related]
2. Response of blood pressure and the renin-angiotensin-aldosterone axis to hypotensive therapy: comparison of propranolol with spironolactone.
Espiner EA; Mansfield H; Miles K
N Z Med J; 1977 Sep; 86(595):216-9. PubMed ID: 343004
[No Abstract] [Full Text] [Related]
3. [Exchangeable sodium, total-body potassium, plasma volume, and hypotensive effect of various diuretics in patients with essential hypertension and low plasma renin level (author's transl)].
Distler A; Keim HJ; Philipp T; Philippi A; Walter U; Werner E
Dtsch Med Wochenschr; 1974 Apr; 99(17):864-9. PubMed ID: 4834874
[No Abstract] [Full Text] [Related]
4. Comparison of chlorthalidone and spironolactone in low--renin essential hypertension.
Kreeft JH; Larochelle P; Ogilvie RI
Can Med Assoc J; 1983 Jan; 128(1):31-4. PubMed ID: 6336600
[TBL] [Abstract][Full Text] [Related]
5. [Relations between hypotensive effect and modifications of volemia and plasma renin activity in patients with essential hypertension treated using spironolactone].
Pessina AC; Corgnati A; Palù CD
Minerva Med; 1977 Feb; 68(8):509-14. PubMed ID: 846681
[TBL] [Abstract][Full Text] [Related]
6. [The effect of alpha methyldopa and spironolactone on angiotensin sensitivity in man].
Káldor A; Kállay K; Sebestyén K; Alexits K
Orv Hetil; 1972 Jan; 113(1):23-4. PubMed ID: 4333395
[No Abstract] [Full Text] [Related]
7. [Correlations between blood pressure, blood volume and plasma renin during therapy with diuretics in essential hypertension. Comparison between the mineralocorticoid antagonist spironolactone and the "loop" diuretic mefruside].
Beretta-Piccoli C; Weidmann P; de Châtel R; Hirsch D; Reubi FC
Schweiz Med Wochenschr; 1977 Jan; 107(4):104-15. PubMed ID: 834983
[TBL] [Abstract][Full Text] [Related]
8. The spironolactone, amiloride, losartan, and thiazide (SALT) double-blind crossover trial in patients with low-renin hypertension and elevated aldosterone-renin ratio.
Hood SJ; Taylor KP; Ashby MJ; Brown MJ
Circulation; 2007 Jul; 116(3):268-75. PubMed ID: 17606839
[TBL] [Abstract][Full Text] [Related]
9. Diuretic therapies in low renin and normal renin essential hypertension.
Brooks CS; Johnson CA; Kotchen JM; Kotchen TA
Clin Pharmacol Ther; 1977 Jul; 22(1):14-20. PubMed ID: 326459
[TBL] [Abstract][Full Text] [Related]
10. Studies on essential hypertension with suppressed plasma renin activity: sodium excretion pattern on salt restriction and effects of spironolactone on blood pressure and plasma renin activity.
Uchida K; Morimoto S; Takeda R; Murakami M
Jpn Circ J; 1972 Dec; 36(12):1301-11. PubMed ID: 4679217
[No Abstract] [Full Text] [Related]
11. The patient with mild to moderate essential hypertension: peripheral renin activity and a comparative drug study.
Merkle GW; Bader PI; Creason PL; Townsend DW; Conn PS; Lakes MK; Campbell NM
J Indiana State Med Assoc; 1981 Jul; 74(7):444-9. PubMed ID: 7024422
[No Abstract] [Full Text] [Related]
12. Aldosterone-to-renin ratio, arterial stiffness, and the response to aldosterone antagonism in essential hypertension.
Mahmud A; Feely J
Am J Hypertens; 2005 Jan; 18(1):50-5. PubMed ID: 15691617
[TBL] [Abstract][Full Text] [Related]
13. Plasma renin activity in the diagnosis of primary aldosteronism: failure to distinguish primary aldosteronism from essential hypertension.
Jose A; Kaplan NM
Arch Intern Med; 1969 Feb; 123(2):141-6. PubMed ID: 5812600
[No Abstract] [Full Text] [Related]
14. Spironolactone and hydrochlorothiazide in essential hypertension. Blood pressure response and plasma renin activity.
Adlin EV; Marks AD; Channick BJ
Arch Intern Med; 1972 Dec; 130(6):855-8. PubMed ID: 5082465
[No Abstract] [Full Text] [Related]
15. [Use of spironolactone and indapamide in the treatment of low-renin arterial hypertension].
Naudzhunas A; Bagdonas G; Yankauskene L; Kazanavichus G
Ter Arkh; 2006; 78(2):61-4. PubMed ID: 16613101
[TBL] [Abstract][Full Text] [Related]
16. Does aldosterone-to-renin ratio predict the antihypertensive effect of the aldosterone antagonist spironolactone?
Mahmud A; Mahgoub M; Hall M; Feely J
Am J Hypertens; 2005 Dec; 18(12 Pt 1):1631-5. PubMed ID: 16364838
[TBL] [Abstract][Full Text] [Related]
17. [Primary hypertension with low plasma renin level].
Klaus D; Klumpp F; Zehner J
Dtsch Med Wochenschr; 1973 Oct; 98(42):1980-7. PubMed ID: 4591648
[No Abstract] [Full Text] [Related]
18. Normokalemic hyperaldosteronism in patients with resistant hypertension.
Benchetrit S; Bernheim J; Podjarny E
Isr Med Assoc J; 2002 Jan; 4(1):17-20. PubMed ID: 11802302
[TBL] [Abstract][Full Text] [Related]
19. The syndrome of essential hypertension and suppressed plasma renin activity. Normalization of blood pressure with spironolactone.
Carey RM; Douglas JG; Schweikert JR; Liddle GW
Arch Intern Med; 1972 Dec; 130(6):849-54. PubMed ID: 5082464
[No Abstract] [Full Text] [Related]
20. Renin unresponsiveness and the effects of oxprenolol, methyldopa and spironolactone in pateints with essential hypertension.
Thomas GW; Ledingham JG; Beilin LJ; Yeates KM
Aust N Z J Med; 1976 Aug; 6(3 Suppl):44-8. PubMed ID: 798576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
